Burning Rock Biotech (BNR) Interest Expenses (2019 - 2025)

Burning Rock Biotech's Interest Expenses history runs 7 years deep, the most recent figure standing at $87.0 million for Q4 2025.

• In Q4 2025, Interest Expenses rose 4.85% year-over-year to $87.0 million; the TTM figure through Dec 2025 stood at $87.0 million (up 4.85% YoY), while the FY2025 annual figure was $88.2 million, up 8.06% from the prior year.
• Interest Expenses for Q4 2025 stood at $87.0 million, up from $83.0 million in the prior quarter.
• The five-year high for Interest Expenses was $87.0 million in Q4 2025, with the low at $41.3 million in Q4 2021.
• The 5-year median for Interest Expenses is $74.4 million (2023), against an average of $69.4 million.
• The sharpest annual moves came in 2021 and 2025: Interest Expenses surged 230029.72% in 2021, then grew 4.85% in 2025.
• Burning Rock Biotech's Interest Expenses stood at $41.3 million in 2021, then soared by 48.64% to $61.4 million in 2022, then gained by 21.06% to $74.4 million in 2023, then gained by 11.56% to $83.0 million in 2024, then advanced by 4.85% to $87.0 million in 2025.
• Business Quant data shows BNR's Interest Expenses at $87.0 million in Q4 2025, $83.0 million in Q4 2024, and $74.4 million in Q4 2023.